Filing Flows

Filing Flows › Ultralife (ULBI) › Guidance & outlook

Ultralife (ULBI) guidance and outlook

Ultralife's 10-Q filed Nov 5, 2026 makes 28 forward-looking statements.

Guidance and outlook

Ultralife: what its forward-looking statements are about (10-Q filed 2026-11-05)Ultralife: what its forward-looking statements are about (10-Q filed 2026-11-05)Other14Costs4Deals3Financing3Demand2People1Tax1
28 statements; tone +0.11 (−1 all cautious, +1 all confident); 8 hedged.
Ultralife: outlook statements against the filing beforeUltralife: outlook statements against the filing beforeConfident6Cautious3

Forward-looking statements, 10-Q filed Nov 5, 2026

Ultralife's latest quarter

Ultralife, Q3 2026: revenue $48.3M (+11% year over year), operating margin 6.6%, net earnings $2.4M, operating cash flow −$2.9M. The chart follows the revenue to costs, profit and cash.

Questions

What does Ultralife expect?

As explained below, our rebranding initiative will eliminate or de-emphasize our reference to the sub-brands going forward. By streamlining our global identity, we aim to strengthen customer recognition, enhance operational efficiency and better align to our customers’ needs with a singular, powerful brand narrative. We believe this transformation will position Ultralife for ongoing growth and stronger market impact as we continue to lead in mission critical battery and RF power solutions.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.